Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_e177bbff06258f9c256892611b22adda |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D10B2509-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D06M2101-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2420-02 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-20 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D01F9-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C08B37-003 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-722 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-24 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28023 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P7-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/B01J20-28033 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-0042 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L24-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/D06M13-207 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L15-28 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-28 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61L15-64 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-722 |
filingDate |
2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bc2c08f811d3254f4c56661bb30ce88b http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_417832a9c4a231ab1cc032460ca4aab4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ac9032bb0149e1521323d57dedf626fb |
publicationDate |
2014-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
GB-2514597-A |
titleOfInvention |
Degradable haemostat composition |
abstract |
A haemostat composition comprising a chitosan, chitosan salt or chitosan derivative, wherein the haemostat composition is in a fibrous form, and is able to fully degrade in a human or animal body within about 30 days. The fibres may have an average length of 3-500mm and a diameter of no more than 100 microns and may form a textile fabric or a pad. Preferably the composition completely degrades between 7-30 days, which may be aided by the composition further comprising a physiologically acceptable acid. The acid may comprise an organic acid such as a carboxylic acid, or an inorganic acid such as hydrochloric acid and/or sulphuric acid. A method of manufacturing the haemostat composition and the use of the composition in absorbing or stemming glow of a liquid discharged from a physiological target is also claimed. In one embodiment the chitosan is washed with an alkali solution to remove endotoxins prior to use. |
priorityDate |
2013-05-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |